MedTrace Logo

Rheumatic Diseases: Evaluation of Health LIteracy, Medication adhereNce and Knowledges

NCT04187794 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2021-07-16

No results posted yet for this study

Summary

A medication non-adherence is reported in chronic rheumatic diseases, in a context of complex and long-term treatments (injectable/per os targeted therapies, biosimilar...). Understanding and integrating the patient into a shared medical decision are key factors for adherence. From this perspective, the level of literacy (an individual's ability to find, understand and use health information) must be explored in order to adapt the communication of information. These are currently insufficiently adapted to the individual understanding of patients. In practice, literacy assessment is very poorly integrated into routine care, while several tools are validated in French. In rheumatology, foreign studies have shown that literacy is positively related to knowledge level. The results remain contradictory regarding its association with medication adherence. Today, the literacy level of patients with rheumatic diseases and its impact on adherence has not been studied in France, although these evaluations would be useful to adapt interventions individually. The acceptance of patients to complete a literacy assessment questionnaire during their care should also be analysed as a condition of its deployment.

Conditions

  • Rheumatic Diseases
  • Treatment Adherence

Interventions

OTHER

Interview patient

to investigate an association between literacy level and medication adherence in patients with rheumatic diseases.

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Principal Investigators

  • Anne Laure YAILIAN, PD · Service hospitalier de rhumatologie

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-09
Primary Completion
2021-06-28
Completion
2021-06-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04187794 on ClinicalTrials.gov